The window for postexposure prophylaxis against Covid-19 is narrow. 1-3 Therapy that is initiated up to 4 days after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is early ...
EAST BRUNSWICK N.J.--(BUSINESS WIRE)--Rising Pharma Holdings, Inc., operating as Rising Pharmaceuticals, today announced the donation of Hydroxychloroquine tablets in support of a Phase 2 randomized ...
Hydroxychloroquine doesn’t protect against COVID-19 in people who have come in contact with the SARS-CoV-2 virus at home or work, according to a randomized, placebo-controlled trial published this ...
Over 69.41 million people around the world have been infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, of these, over 1.49 million people have lost their lives. The ...
NEW YORK--(BUSINESS WIRE)--Hydroxychloroquine, a widely available and inexpensive drug initially used for malaria as well as lupus and rheumatoid arthritis, has been the subject of intense medical and ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Hydroxychloroquine did not prevent illness similar to, ...
With 26 million confirmed cases and more than 291,000 deaths due to COVID-19, India has been hit hard by the pandemic. The country's health care system is overwhelmed, its crematoriums are running at ...
Patients were then assigned to receive either placebo (n= 354) or hydroxychloroquine 800mg once, followed in 6-8 hours by 600mg, and then 600mg once daily for 4 consecutive days. The use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results